Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
With
Celerion
Q2 Solutions
Altasciences Company Inc.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy adult males and/or females, 18 to 55 years of age (inclusive) at the time of screening.
BMI at screening between 18.0 and 32.0 kg/m2 (inclusive)
Females will not be pregnant or lactating, and females of childbearing potential and males will agree to use contraception.
Able to comprehend and willing to sign an ICF and to abide by the study restrictions.
You may not be if
Significant history or clinical manifestation of any major system disorder, as determined by the investigator (or designee).
History of significant hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance, unless approved by the investigator (or designee).
Use of any prescription medication before the first study drug administration (within 14 days before initial study drug administration or within 5 half-lives of the prescription medication, whichever is longer), and until after the last protocol-specified blood sample is prohibited, other than use of hormonal contraception.
Clinically significant abnormal 12 lead ECGs
Personal history of unexplained syncopal events, or family history of long QT syndrome or sudden unexplained death in a young person.
Presence of any other condition (including surgery) known to interfere with the absorption, distribution, metabolism, or excretion of medicines.
History of drug or alcohol abuse in the last 6 months
Positive hepatitis panel and/or positive human immunodeficiency virus test.
